Edwin van Velzen, MD, Aart Brutel de la Rivière, MD, PhD, Hans J

Slides:

Advertisements

Similar presentations

Volume 110, Issue 6, Pages (December 1996)

Advertisements

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Elizabeth A. David, MD, David T

Thomas J. Birdas, MD, Richard P. M

Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients Ze Fen Xiao, MD, Zong Yi Yang, MD, Jun Liang, MD, Yan.

Effect of tumor size on prognosis in patients with non–small cell lung cancer: The role of segmentectomy as a type of lesser resection Morihito Okada,

Quality of life after tailored combined surgery for stage I non–small-cell lung cancer and severe emphysema Eugenio Pompeo, MD, Enrico De Dominicis,

Standard Uptake Value Predicts Survival in Non–Small Cell Lung Cancer

Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis

Completion pneumonectomy: analysis of operative mortality and survival

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Surgical Results and Prognostic Factors in Early Non–Small Cell Lung Cancer José Padilla, MD, Vı́ctor Calvo, MD, Juan C Peñalver, MD, Gabriel Sales, MD,

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Video-Assisted Thoracic Surgery Lobectomy: Experience With 1,100 Cases

Meta-Analysis of Positron Emission Tomographic and Computed Tomographic Imaging in Detecting Mediastinal Lymph Node Metastases in Nonsmall Cell Lung Cancer

Tumors of the esophagogastric junction

Primary Pulmonary Malignant Meningioma

Lymph Node Evaluation Achieved by Open Lobectomy Compared With Thoracoscopic Lobectomy for N0 Lung Cancer Robert E. Merritt, MD, Chuong D. Hoang, MD,

Survival related to lymph node involvement in lung cancer after sleeve lobectomy compared with pneumonectomy Morihito Okada, MD, Hiroyuki Yamagishi,

Sex-associated differences in survival of patients undergoing resection for lung cancer Mark K Ferguson, MD, Jun Wang, MD, Philip C Hoffman, MD, Daniel.

Lung Cancer Surgery in Patients With Liver Cirrhosis

Thomas J. Birdas, MD, Richard P. M

Dylan R. Nieman, MD, PhD, Christian G. Peyre, MD, Thomas J

Prognostic Factors in Patients with Pathologic T1-2N1M0 Disease in Non-small Cell Carcinoma of the Lung Katsunari Matsuoka, MD, Shinichi Sumitomo, MD,

Mediastinal Lymph Node Examination and Survival in Resected Early-Stage Non– Small-Cell Lung Cancer in the Surveillance, Epidemiology, and End Results.

Prognostic factors in clinical stage I non–small cell lung cancer

Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance Toshihiro Osaki, MD, PhD, Akira Nagashima, MD, PhD, Takashi Yoshimatsu,

Repke J Snijder, Aart Brutel de la Rivière, Hans J. J Elbers, Jules M

Non–Small Cell Lung Cancer at the Extremes of Age: Impact on Diagnosis and Treatment William C Nugent, MD, Mark T Edney, BA, Paul G Hammerness, BA, Bradley.

Prognostic Significance of Surgical-Pathologic N1 Lymph Node Involvement in Non- Small Cell Lung Cancer Adalet Demir, MD, Akif Turna, MD, PhD, FETCS,

Number of Lymph Nodes Associated With Maximal Reduction of Long-Term Mortality Risk in Pathologic Node-Negative Non–Small Cell Lung Cancer Raymond U.

Smoking Status as a Prognostic Factor in Patients with Stage I Pulmonary Adenocarcinoma Ichiro Yoshino, MD, PhD, Daigo Kawano, MD, Taro Oba, MD, Koji.

Survival After Surgery for Pathologic Stage IA Non-Small Cell Lung Cancer Associated With Idiopathic Pulmonary Fibrosis Yuichi Saito, MD, Yasuyuki Kawai,

Recurrence and Survival After Segmentectomy in Patients With Prior Lung Resection for Early-Stage Non-Small Cell Lung Cancer Lisa M. Brown, MD, Brian.

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Primary Cardiac Sarcoma

Importance of Lymph Node Dissection in Thymic Carcinoma

Renal Cell Carcinoma Lung Metastases Surgery: Pathologic Findings and Prognostic Factors Jalal Assouad, MD, Boriana Petkova, MD, Pascal Berna, MD, Antoine.

High Expression of p300 Has an Unfavorable Impact on Survival in Resectable Esophageal Squamous Cell Carcinoma Yong Li, MD, Hao-Xian Yang, MD, Rong-Zhen.

Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung Marc Riquet, MD, Dominique Manac’h, MD, Françoise Le.

Selective Mediastinal Lymphadenectomy for Clinico-Surgical Stage I Non–Small Cell Lung Cancer Morihito Okada, MD, PhD, Toshihiko Sakamoto, MD, PhD, Tsuyoshi.

Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or Segmentectomy Haiyu Zhou, MD, Luis F. Tapias, MD, Henning A.

Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant? Daniel J. Tandberg,

Surgical Treatment for Limited-Stage Primary Small Cell Cancer of the Esophagus Dongrong Situ, MD, Yongbin Lin, MD, PhD, Hao Long, MD, PhD, Lanjun Zhang,

Number of Metastatic Lymph Nodes in Resected Non–Small Cell Lung Cancer Predicts Patient Survival Jin Gu Lee, MD, Chang Young Lee, MD, In Kyu Park, MD,

Douglas E. Paull, MD, Glenda M. Updyke, PA-C, Michael A

Adjuvant Surgery after Carboplatin and VP16 in Resectable Small Cell Lung Cancer Giulia Veronesi, MD, Paolo Scanagatta, MD, Francesco Leo, MD, Tommaso.

Lewis Y antigen expression and postoperative survival in non–small cell lung cancer Fumihiro Tanaka, MD, Ryo Miyahara, MD, Yohsuke Ohtake, MD, Kazuhiro.

Carcinoma of the esophagus: Prognostic significance of histologic type

Predictors of Survival After Operation Among Patients With Large Cell Neuroendocrine Carcinoma of the Lung Florian Eichhorn, MD, Hendrik Dienemann, MD,

O. S. Breathnach, MDa, D. J. Kwiatkowski, MD, PhDb, D. M

Menopausal effects on presentation, treatment, and survival of women with non–small cell lung cancer Kimberly A Moore, MD, Carlos M Mery, MD, MPH, Michael.

Resected Synchronous Primary Malignant Lung Tumors: A Population-Based Study Hans Rostad, MD, PhD, Trond-Eirik Strand, MD, Anne Naalsund, MD, Jarle Norstein,

Treatment Outcomes of Patients With Different Subtypes of Large Cell Carcinoma of the Lung Yung-Han Sun, MS, Shih-Wei Lin, PhD, Chih-Cheng Hsieh, MD,

Neal S Goldstein, MD The Annals of Thoracic Surgery

What is the optimal distal resection margin for esophageal carcinoma?

Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer Steven M Keller, MD, Sudeshna Adak,

Pneumonectomy After Chemoradiation Therapy for Non-Small Cell Lung Cancer: Does “Side” Really Matter? Anthony W. Kim, MD, L. Penfield Faber, MD, William.

Effect of Formalin Fixation on Tumor Size Determination in Stage I Non-Small Cell Lung Cancer Po-Kuei Hsu, MD, Hsu-Chih Huang, MD, Chih-Cheng Hsieh,

Nonanatomic prognostic factors in resected nonsmall cell lung carcinoma: the importance of perineural invasion as a new prognostic marker Adnan Sayar,

Survival and Outcomes of Pulmonary Resection for Non-Small Cell Lung Cancer in the Elderly: A Nested Case-Control Study Robert J. Cerfolio, MD, Ayesha.

Mark I. Block, MD The Annals of Thoracic Surgery

Domenico Galetta, MD, PhD, Lorenzo Spaggiari, MD, PhD

Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma Joachim Pfannschmidt, MD, Hans Hoffmann, MD, PhD, Thomas.

Lung Cancer Invading the Pericardium: Quantum of Lymph Nodes

Long-Term Results of Sleeve Lobectomy in the Management of Non–Small Cell Lung Carcinoma and Low-Grade Neoplasms Robert E. Merritt, MD, Douglas J. Mathisen,

A phase II single-institution study of neoadjuvant stage IIIA/B chemotherapy and radiochemotherapy in non-small cell lung cancer Andreas Granetzny, MD,

Reappraise the advanced technique for tumor localization and sentinel lymph node assessment in clinical early-stage non–small cell lung cancer Chengwu.

The risk of second primary tumors after resection of stage I nonsmall cell lung cancer David Rice, MB, BCh, Hyung-Woo Kim, MS, Anita Sabichi, MD, Scott.

Presentation transcript:

Type of lymph node involvement and survival in pathologic N1 stage III non–small cell lung carcinoma Edwin van Velzen, MD, Aart Brutel de la Rivière, MD, PhD, Hans J.J Elbers, MD, PhD, Jan-Willem J Lammers, MD, PhD, Jules M.M van den Bosch, MD, PhD The Annals of Thoracic Surgery Volume 67, Issue 4, Pages 903-907 (April 1999) DOI: 10.1016/S0003-4975(99)00123-X

Fig 1 Cumulative 5-year survival curves for patients with pathologic N1 T3 disease (solid line) and T4 disease (broken line). (+ = censored patient; T3: 17 patients censored; T4: 10 patients censored.) The Annals of Thoracic Surgery 1999 67, 903-907DOI: (10.1016/S0003-4975(99)00123-X)